Guggenheim Capital’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-115,289
| Closed | -$5.34M | – | 2200 |
|
|
2019
Q2 | $5.34M | Sell |
115,289
-55,354
| -32% | -$1.55M | 0.04% | 564 |
|
|
2019
Q1 | $4.16M | Sell |
170,643
-32,204
| -16% | -$670K | 0.03% | 714 |
|
|
2018
Q4 | $2.89M | Sell |
202,847
-26,260
| -11% | -$398K | 0.02% | 853 |
|
|
2018
Q3 | $3.48M | Buy |
229,107
+22,743
| +11% | +$349K | 0.02% | 933 |
|
|
2018
Q2 | $3.46M | Sell |
206,364
-554
| -0.3% | -$8.81K | 0.02% | 927 |
|
|
2018
Q1 | $3.38M | Sell |
206,918
-43,096
| -17% | -$690K | 0.01% | 1267 |
|
|
2017
Q4 | $3.2M | Sell |
250,014
-46,608
| -16% | -$530K | 0.01% | 1308 |
|
|
2017
Q3 | $3.65M | Sell |
296,622
-27,344
| -8% | -$254K | 0.01% | 1255 |
|
|
2017
Q2 | $2.71M | Buy |
323,966
+68,525
| +27% | +$560K | 0.01% | 1408 |
|
|
2017
Q1 | $2.28M | Sell |
255,441
-12,737
| -5% | -$136K | 0.01% | 1561 |
|
|
2016
Q4 | $2.36M | Buy |
+268,178
| New | +$1.97M | 0.01% | 1545 |
|
|
2016
Q1 | – | Sell |
-12,195
| Closed | -$51K | – | 3030 |
|
|
2015
Q4 | $51K | Buy |
+12,195
| New | +$55.7K | ﹤0.01% | 2891 |
|
|
2015
Q3 | – | Sell |
-698,115
| Closed | -$5.03M | – | 3057 |
|
|
2015
Q2 | $5.03M | Buy |
698,115
+498,211
| +249% | +$3.68M | 0.01% | 1154 |
|
|
2015
Q1 | $1.47M | Buy |
199,904
+184,362
| +1,186% | +$1.31M | ﹤0.01% | 2023 |
|
|
2014
Q4 | $74K | Sell |
15,542
-4,521
| -23% | -$17.9K | ﹤0.01% | 2878 |
|
|
2014
Q3 | $71K | Buy |
+20,063
| New | +$79.1K | ﹤0.01% | 2907 |
|
|
2014
Q1 | – | Sell |
-482,613
| Closed | -$2.42M | – | 3390 |
|
|
2013
Q4 | $2.42M | Buy |
482,613
+54,043
| +13% | +$294K | 0.01% | 1610 |
|
|
2013
Q3 | $2.67M | Buy |
+428,570
| New | +$2.55M | 0.01% | 1427 |
|